TenoxicamThird Party Manufacturing in India

Tenoxicam is a non-steroidal anti-inflammatory drug (NSAID) from the oxicam class. It works by inhibiting the cyclooxygenase enzymes COX-1 and COX-2, which are responsible for converting arachidonic acid into prostaglandins, prostacyclin, and thromboxanes. Prostaglandins are key mediators of inflammation, pain, and fever — by reducing their synthesis, tenoxicam produces its anti-inflammatory, analgesic, and antipyretic effects.

With a long plasma half-life of 30-140 hours, tenoxicam provides sustained therapeutic action that allows once-daily dosing. It also demonstrates free radical scavenging activity and antioxidant effects that may contribute to its anti-inflammatory efficacy. These properties make it particularly effective for chronic inflammatory conditions where continuous suppression of inflammation is needed.

Therapeutic Uses

Tenoxicam is prescribed for:

• Rheumatoid Arthritis: Reduces joint pain, swelling, and morning stiffness in chronic inflammatory arthritis
• Osteoarthritis: Provides symptomatic relief of pain and improves joint function
• Ankylosing Spondylitis: Effective in managing spinal inflammation and stiffness
• Acute Musculoskeletal Pain: Treats acute back pain, tendonitis, and bursitis
• Post-Operative Pain: Used for short-term management of acute pain after surgery
• Dysmenorrhea: Relieves pain associated with menstrual cramps

Why Manufacturers Choose Tenoxicam

Tenoxicam is a well-established NSAID with strong prescription demand across Asia, Europe, and Latin America. Its once-daily dosing regimen and balanced efficacy-safety profile make it a preferred choice over older NSAIDs for chronic inflammatory conditions. The 20mg lyophilized injection formulation offers a rapid onset option for acute pain management in hospital settings, while the molecule's availability in multiple dosage forms (tablets, injections) provides manufacturing flexibility. Indian WHO-GMP certified manufacturers are key suppliers to both domestic and export markets.

This makes Tenoxicam a valuable molecule for third party manufacturing in India, with steady demand from hospital tenders, PCD franchise networks, and export-oriented pharmaceutical companies targeting regulated markets.